Literature DB >> 7073323

Q fever hazards from sheep and goats used in research.

R Ruppanner, D Brooks, C E Franti, D E Behymer, D Morrish, J Spinelli.   

Abstract

Two recent outbreaks of Q fever in research institutions prompted the authors to review extant data, in an effort to delineate hazards to humans from small ruminants used in research. Prevalence of Q fever antibodies was 24% among 2097 sheep and 57% among 1475 goats from various sources. In a facility using sheep for prenatal research, in which an epidemic of human Q fever later occurred, antibody prevalence among sheep was 77%, with larger than usual proportions of high (greater than or equal to 128) titers. Antibody prevalence was 5% in a sample from the general human population and 11% among 347 persons at three research institutions (17% among students, 8% among the research staff). Except for animal caretakers routinely exposed to sheep, antibody prevalence among research staff approximated prevalence in the general population. Suggestions are made for surveillance and vaccination of sheep and goats used in medical research institutions.

Entities:  

Mesh:

Year:  1982        PMID: 7073323     DOI: 10.1080/00039896.1982.10667545

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  4 in total

1.  Q fever: hazard from sheep used in research.

Authors:  A E Simor; J L Brunton; I E Salit; H Vellend; L Ford-Jones; L P Spence
Journal:  Can Med Assoc J       Date:  1984-04-15       Impact factor: 8.262

Review 2.  Q fever.

Authors:  L G Reimer
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

Review 3.  Q fever: an emerging public health concern in Canada.

Authors:  G H Lang
Journal:  Can J Vet Res       Date:  1989-01       Impact factor: 1.310

4.  Domestic sheep show average Coxiella burnetii seropositivity generations after a sheep-associated human Q fever outbreak and lack detectable shedding by placental, vaginal, and fecal routes.

Authors:  Ryan D Oliveira; Michelle R Mousel; Kristy L Pabilonia; Margaret A Highland; J Bret Taylor; Donald P Knowles; Stephen N White
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.